Announcements Trials
Browse Landscape

Phase

Phase 3 5Phase 4 3Phase NA 2Phase EARLY_PHASE1 1Phase 2 1Phase 1 1

Status

Completed 32Unknown 7Terminated 3Withdrawn 1Recruiting 1Enrolling by invitation 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Dermatologic 3

Conditions

Breast Neoplasms 18Neoplasms 16Prostatic Neoplasms 12Neoplasm Metastasis 10Pain 9Colorectal Neoplasms 9Carcinoma, Non-Small-Cell Lung 9Lung Neoplasms 8Polycystic Ovary Syndrome 7Leiomyoma 6Anemia 5Skin Neoplasms 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Pancreatic Neoplasms 4Ovarian Neoplasms 4Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4Leukemia 4Carcinoma, Renal Cell 4Recurrence 3Melanoma 3Liver Neoplasms 3Kidney Neoplasms 3Keratosis, Actinic 3Insulin Resistance 3Carcinoma, Hepatocellular 3Cancer Pain 3Brain Neoplasms 3Uterine Cervical Neoplasms 2Thyroid Neoplasms 2Stomach Neoplasms 2

Interventions

Photochemotherapy 2Imiquimod 2Aminolevulinic Acid 2methyl 5-aminolevulinate 1Solutions 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Terminated × Keratosis, Actinic × Clear all
NCT03963102 2024-07-26

Duration of Ameluz Application in Acral Actinic Keratoses Response

Royal Cornwall Hospitals Trust

Phase 4 Terminated
28 enrolled
Dermatologic

Keratosis, Actinic

NCT01538901 2017-09-12

AKtransplant

Medical University of Vienna

Phase 4 Terminated
10 enrolled
Dermatologic

Keratosis, Actinic

NCT01203878 2014-12-08

Treatment of Actinic Keratoses of the Face With Imiquimod 3.75% Cream Followed by Photodynamic Therapy

Tennessee Clinical Research Center

Phase 4 Terminated
21 enrolled 10 charts
Dermatologic

Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡